Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v8-FR
Language English French
Date Updated 2020-05-29 2020-05-08
Drug Identification Number 02403196 02403196
Brand name ACT CLARITHROMYCIN XL ACT CLARITHROMYCIN XL
Common or Proper name CLARITHROMYCIN FC TABLETS 500MG CLARITHROMYCIN FC TABLETS 500MG
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients CLARITHROMYCIN CLARITHROMYCIN
Strength(s) 500MG 500MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60 60
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2020-05-15 2020-05-15
Estimated end date 2020-06-30 2020-08-31
Actual end date 2020-05-27
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Allocating to 100% of our market. Allocating to 100% of our market.
Health Canada comments